Cargando…
A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting
OBJECTIVE: To evaluate the overall long-term effectiveness of aripiprazole in patients with schizophrenia in a general psychiatric practice setting in Taiwan. METHODS: This was a prospective, open-label, multicenter, post-market surveillance study in Taiwanese patients with a Diagnostic and Statisti...
Autores principales: | Hsieh, Ming-Hong, Lin, Wei-Wen, Chen, Shao-Tsu, Chen, Kao-Ching, Chen, Kuang-Peng, Chiu, Nan-Ying, Huang, Chao, Chang, Ching-Jui, Lin, Cheng-Hsiu, Lai, Te-Jen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949853/ https://www.ncbi.nlm.nih.gov/pubmed/20849577 http://dx.doi.org/10.1186/1744-859X-9-35 |
Ejemplares similares
-
Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Andrade, Chittaranjan
Publicado: (2004) -
Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Chavda, R.K., et al.
Publicado: (2004) -
The prevalence of childhood trauma in psychiatric outpatients
por: Devi, Fiona, et al.
Publicado: (2019) -
Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis
por: Lee, Seung-Yup, et al.
Publicado: (2016) -
Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial
por: Ghanizadeh, Ahmad
Publicado: (2016)